sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Mon May 25
Chubb Limited (CB): One of the Best Financial Stocks to Buy Per Warren Buffett?
3d
Y
Namibia's communication regulator dismisses Starlink appeal over license rejection
3d
Y
Got $1,000? Why Broadcom's Guidance Created the Ultimate Artificial Intelligence (AI) Buying Opportunity.
3d
Y
SpaceX Falls After Bond Offering, New Analyst Coverage. Space Stocks Drop Below Key Levels.
3d
Y
Tigo Energy (TYGO) Gains from Higher Energy Prices
3d
Y
Micron Stock Heads Into Q3 Earnings: Soaring Profit Builds Case for Further Upside
3d
Y
Generation Mining secures $141m loan for Marathon project
3d
Y
Dollar Recovers as Euro Retreats on Dovish Lagarde Comments
3d
Y
How Is C.H. Robinson's Stock Performance Compared to Other Transportation Stocks?
3d
Y
Paysign’s (PAYS) Quarterly Results Defy Disruption Fears
3d
Y
SpaceX Stock Tumbles More Than 16%
3d
Y
Uber-Backed Bike And Scooter Rental Firm Lime Seeks $1.8 Billion Valuation In IPO
3d
Y
Is Duos Technologies Group (DUOT) a Mispriced Opportunity?
3d
Y
SpaceX Stock Is Up. Here Are 4 Reasons I'm Still Not Buying.
3d
Y
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
3d
Y
Tech stocks live: Tech stocks mixed ahead of Micron earnings Wednesday
3d
Y
Tech stocks live: Semiconductor stocks steady after sell-off, with Micron earnings on deck
3d
Y
Tech stocks live: Micron stock jumps over 12% on earnings beat after tumbling earlier this week
3d
Y
Tech stocks live: Google and other tech stocks extend losses as AI worries creep back in
3d
Y
Tech stocks live: AI trade roars back after Micron earnings crush estimates
3d
Y
Tech stocks live: AI memory trade roars back after Micron earnings crush estimates
3d
Y
Kalshi reportedly in discussions with investment banks about IPO
3d
Y
KPMG Australia faces scrutiny over misuse of Optus information – report
3d
Y
Canada food retail prices continue to outpace inflation
3d
Y
Are Your Retirement Savings Safe? Inside Insurance Ratings & the Annuity Boom
3d
Y
A US soldier was arrested for betting with classified intel — now regulators want to crack down on prediction markets
3d
Y
TurboTax-Maker Intuit Leads 3 Cheap Tech Stocks That Pay You to Wait on the AI Boom
3d
Y
Profound Medical Corp. (PROF) Dropped Despite High Potential
3d
Y
Foodics acquires Greece-based hospitality business Norma AI
3d
Y
Super Micro Jumps 11%, Dell Rises 5% as New NVIDIA Vera Rubin Systems Fuel the AI Server Trade
3d
Y
‘I became invisible when I turned 60’: The hidden crisis of late-career unemployment
3d
Y
As Crude Oil Prices Fall, Make This 1 Bullish Trade Instead
3d
Y
Lucid Motors layoffs: new CEO cuts 18% of workforce
3d
Y
SpaceX Merger Would Hurt Tesla Stock, Jefferies Says. Cathie Wood Adds Tesla.
3d
Y
Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising
3d
Y
Astera Labs’ (ALAB) Growth Rate Weakens Despite Earnings Growth
3d
Y
Bitcoin Price Could Fall to $23,000 in 2026 if Stock Market Crashes Over 50% — Is It Likely?
3d
Y
Uber board sued over alleged 'serial' compliance failures, sexual abuse lawsuits
3d
Y
Massive Wave of Selling Is Coming, Says JPMorgan. Here’s Why It Probably Won’t Matter
3d
Y
Is XRP (Ripple) Expected to Skyrocket?
3d
Y
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debut
3d
Y
SpaceX stock down again, shaving off some IPO gains; confirms debt offering
3d
Y
BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline
3d
Y
Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries
3d
Y
Can Rhythm Pharmaceuticals (RYTM) ’s New Data Help Patients With a Rare Hunger Disorder?
3d
Y
Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device
3d
Y
Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin
3d
Y
Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?
3d
Y
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
3d
Y
Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine
3d
Y
More →